ResearcherUniversity of DebrecenNo recent work listed

Xu‐Feng Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5895-2253; OpenAlex author ID A5002681207. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation. Co-author DOI 10.3389/fimmu.2023.1097403 ↗
Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity. Co-author DOI 10.3389/fimmu.2022.978865 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shujing Zhou · 2 shared papers, 2022–2023 · strength 0.38
- Paper Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivi… DOI 10.3389/fimmu.2022.978865 ↗
- Paper NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation. DOI 10.3389/fimmu.2023.1097403 ↗
András Hajdú · 1 shared paper, 2022 · strength 0.20
- Paper Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivi… DOI 10.3389/fimmu.2022.978865 ↗
Hajdu András · 1 shared paper, 2022 · strength 0.20
- Paper Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivi… DOI 10.3389/fimmu.2022.978865 ↗
Min Xu · 1 shared paper, 2023 · strength 0.18
- Paper NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation. DOI 10.3389/fimmu.2023.1097403 ↗
Qi Wang · 1 shared paper, 2023 · strength 0.18
- Paper NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation. DOI 10.3389/fimmu.2023.1097403 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.